Results 11 to 20 of about 862,573 (173)

Therapeutic options for carbapenem-resistant Enterobacteriaceae infections

Virulence, 2017
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health. The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been ...
Tumbarello, Mario, Trecarichi, Enrico Maria, Enrico Maria Trecarichi, Mario Tumbarello   +3 more
core   +2 more sources

Carbapenem-resistant genes primer sets.

, 2023
BackgroundCarbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge due to the high morbidity and mortality associated with their ...
Frank Twum Aboagye (17304867), Alex Owusu-Ofori (5931680), Isaac Owusu-Frimpong (11047490), James Sampah (17304864)   +3 more
core   +1 more source

Multidrug-resistant organisms may be associated with bed allocation and utilization efficiency in healthcare institutions, based on national monitoring data from China (2014–2020)

Scientific Reports, 2023
Analyzing the influence of the bed allocation and utilization efficiency in healthcare institutions on the isolation proportion of Multidrug-resistant organisms (MDROs) to provide data to support prevention and control of MDROs.
Xing-Tian Wang, Hua Meng, Dong-Feng Pan, Xiao-Yu Zheng, Wen-Wen Lu, Chen Chen, Ming Su, Xin-Ya Su, Zhuo Liu, Xiao-Juan Ma, Pei-Feng Liang   +10 more
doaj   +1 more source

Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity

Frontiers in Cellular and Infection Microbiology, 2021
Antibiotic resistance represents a major global concern. The rapid spread of opportunistically pathogenic carbapenemase-encoding bacteria (CEB) requires clinicians, researchers, and policy-makers to swiftly find solutions to reduce transmission rates and
Claudio Neidhöfer, Christian Buechler, Guido Neidhöfer, Gabriele Bierbaum, Irene Hannet, Achim Hoerauf, Marijo Parčina   +6 more
doaj   +1 more source

Carbapenem-resistant gram-negative bacterial prevention practice in nosocomial infection and molecular epidemiological characteristics in a pediatric intensive care unit

Heliyon, 2023
Introduction: The increasing prevalence of carbapenem-resistant gram-negative bacilli infection has emerged as a substantial threat to human health.
Lijun Yin, Nana Wu, Gangfeng Yan, Lu Lu, Huimin Qian, Weijing Yang, Jian Ma, Leiyan He, Guoping Lu, Xiaowen Zhai, Chuanqing Wang   +10 more
doaj   +1 more source

Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection

Brazilian Journal of Infectious Diseases, 2016
Background: Little is known about factors associated with carbapenem-resistant Klebsiella pneumoniae infections in pediatric patients, who are initally colonized with carbapenem-resistant Klebsiella pneumoniae. Materials and methods: A retrospective case–
Hacer Akturk, Murat Sutcu, Ayper Somer, Derya Aydın, Rukiye Cihan, Aslı Ozdemir, Asuman Coban, Zeynep Ince, Agop Citak, Nuran Salman   +9 more
doaj   +1 more source

Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center

Journal of Microbiology, Immunology and Infection, 2019
Background: Acquired carbapenem resistance among non-fermenting Gram-negative bacilli (NFGNB), such as Pseudomonas aeruginosa and Acinetobacter calcoaceticus-Acinetobacter baumannii complex (ACB complex), is a serious problem in nosocomial infections. We
Ying-Chi Huang, Ping-Feng Wu, Yi-Tsung Lin, Fu-Der Wang   +3 more
doaj   +1 more source

Carbapenem Resistant Enterobacteriaceae in Africa

Borneo Journal of Pharmacy, 2020
Carbapenems are regarded as unique among the β-lactam antibiotics due to their broad spectrum of activity and ability to resist β-lactamase hydrolysis.
Bashar Haruna Gulumbe, Olumide Ajibola
doaj   +1 more source

Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend

International Journal of Infectious Diseases, 2019
Background: Bacteraemia due to carbapenem-resistant gram-negative bacteria is challenging. This study examined the burden of carbapenem and colistin resistance in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii bacteraemia in ...
A. Balkhair, Z. Al-Muharrmi, B. Al’Adawi, I. Al Busaidi, H.B. Taher, T. Al-Siyabi, M. Al Amin, K.S. Hassan   +7 more
doaj   +1 more source

Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Aminoglycosides are the drug of choice for the treatment of Pseudomonas aeruginosa infections. Aminoglycoside resistance in P. aeruginosa often occurred via acquired aminoglycoside-modifying enzymes (AMEs).
Yeliz TANRIVERDİ ÇAYCI, Osman Sezer CİRİT, İlknur BIYIK, Canberk ÇINAR, Demet GÜR VURAL, Kemal BİLGİN, Asuman BİRİNCİ   +6 more
doaj   +1 more source